Filing Details
- Accession Number:
- 0000899243-22-008830
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-02 21:29:47
- Reporting Period:
- 2022-02-26
- Accepted Time:
- 2022-03-02 21:29:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Bausch Health Companies Inc. | BHC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1749876 | F Joseph Gordon | 400 Somerset Corporate Boulevard Bridgewater NJ 08807 | Pres&Co-Head Bausch&Lomb/Int'l | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares, No Par Value | Acquisiton | 2022-02-27 | 17,350 | $0.00 | 127,988 | No | 4 | M | Direct | |
Common Shares, No Par Value | Disposition | 2022-02-27 | 6,233 | $24.35 | 121,755 | No | 4 | F | Direct | |
Common Shares, No Par Value | Disposition | 2022-02-26 | 1,522 | $24.35 | 120,233 | No | 4 | F | Direct | |
Common Shares, No Par Value | Disposition | 2022-02-27 | 1,716 | $24.35 | 118,517 | No | 4 | F | Direct | |
Common Shares, No Par Value | Disposition | 2022-03-01 | 6,338 | $23.82 | 112,179 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares, No Par Value | Restricted Share Units | Acquisiton | 2022-02-27 | 17,350 | $0.00 | 17,350 | $0.00 |
Common Shares, No Par Value | Restricted Share Units | Disposition | 2022-02-27 | 17,350 | $24.35 | 0 | $24.35 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2022-02-27 | No | 4 | A | Direct | |
0 | 2022-02-27 | No | 4 | M | Direct |
Footnotes
- Reflects the vesting and conversion of performance-based Restricted Share Units ("PSUs"), previously granted to the reporting person, into common shares, no par value ("Common Shares") of the Issuer.
- Each PSU converts into Common Shares on a one-for-one basis
- This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs.
- This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units ("RSUs").
- This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of RSUs.
- The sales reported in this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2021.